Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$96.76 - $112.03 $112,531 - $130,290
-1,163 Reduced 59.92%
778 $596,000
Q2 2022

Jul 26, 2022

BUY
$102.07 - $123.37 $198,117 - $239,461
1,941 New
1,941 $210,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $214,537 - $237,341
-1,839 Closed
0 $0
Q2 2021

Jul 27, 2021

BUY
$105.79 - $124.53 $194,547 - $229,010
1,839 New
1,839 $213,000
Q1 2021

Apr 27, 2021

SELL
$108.84 - $128.23 $67,154 - $79,117
-617 Closed
0 $0
Q4 2020

Mar 19, 2021

BUY
$105.0 - $114.42 $64,785 - $70,597
617 New
617 $67,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Baron Silver Stevens Financial Advisors, LLC Portfolio

Follow Baron Silver Stevens Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baron Silver Stevens Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baron Silver Stevens Financial Advisors, LLC with notifications on news.